Ngā hua rapu - Cannon, P M

Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors: a new system for anti-human immunodeficiency virus gene therapy. mā Cannon, P M, Kim, N, Kingsman, S M, Kingsman, A J

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Conserved sequences in the carboxyl terminus of integrase that are essential for human immunodeficiency virus type 1 replication. mā Cannon, P M, Byles, E D, Kingsman, S M, Kingsman, A J

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies. mā Luo, L, Li, Y, Cannon, P M, Kim, S, Kang, C Y

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues. mā Cannon, P M, Wilson, W, Byles, E, Kingsman, S M, Kingsman, A J

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. mā Januszeski, M M, Cannon, P M, Chen, D, Rozenberg, Y, Anderson, W F

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus. mā Han, J Y, Cannon, P M, Lai, K M, Zhao, Y, Eiden, M V, Anderson, W F

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A transient three-plasmid expression system for the production of high titer retroviral vectors. mā Soneoka, Y, Cannon, P M, Ramsdale, E E, Griffiths, J C, Romano, G, Kingsman, S M, Kingsman, A J

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. mā Cannon, P M, Matthews, S, Clark, N, Byles, E D, Iourin, O, Hockley, D J, Kingsman, S M, Kingsman, A J

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa